During continuing review of a clinical trial, the reviewing IRB for Dr. Smith terminated approval of the study after determining

Question

vovangra [49]

3 years ago

9

During continuing review of a clinical trial, the reviewing IRB for Dr. Smith terminated approval of the study after determining

that the risks of conducting the study outweighed potential benefits. Dr. Smith is required to: ________

Health

1 answer:

butalik [34] · Answer 1 · 2023-01-13T00:12:53+03:00

Dr. Smith is required to notify the sponsor of the Institutional Review Board (IRB) termination of approval of the clinical trial. The IRB has the authority to consider termination.

<h3>What is the Institutional Review Board? </h3>

The Institutional Review Board (IRB) can be defined as a group of scientists aimed at analyzing research projects for protecting the rights of human subjects.

The IRB has the authority to consider termination when investigations are not being conducted in accordance with its requirements.

Suspension and/or termination of IRB approval occurs where there is serious harm to human subjects.

Learn more about the Institutional Review Board here:

brainly.com/question/8905808